Session Information
Session Type: Abstract Submissions (ACR)
Background/Purpose: Rheumatoid Factor positive polyarthritis (RF+ poly) is the JIA subtype that resembles adult seropositive RA. However, the ILAR classification criteria for RF+ polyarthritis do not capture all children with childhood onset RA due to specific exclusion criteria: lack of 2 (+) RF tests, <5 active joints in the first 6 months, family history of psoriasis, and (+) HLA-B27 in boys with onset after age 6. The ACR/EULAR criteria used for diagnosing adult RA do not have these exclusions, and they include the highly specific anti-CCP antibodies (ACPA). The current ILAR classification system does not include ACPA. Hence, children who are RF (-) but ACPA (+) may be treated less aggressively and develop complications secondary to undertreated disease. Our objectives are to 1) determine whether RF and/or ACPA (+) children meet ILAR criteria for RF+ poly JIA and 2) assess for significant differences between children who meet RF+ poly criteria and those who are classified as other subtypes.
Methods: Demographic and disease-related data were collected from charts of RF and/or ACPA (+) children. Each child was classified using ILAR criteria, and the ACR/EULAR classification was used to determine whether each child met criteria for adult RA. Children with RF+ poly JIA were compared to those with other subtypes. Nominal variables were compared using Chi square or Fisher’s exact tests, and continuous variables were compared using Student’s T test.
Results: Of 49 children with RF and/or ACPA (+) JIA, 29 (59%) met criteria for RF+ poly JIA (Table 1). Of the 20 who did not, 9 (45%) met criteria for undifferentiated JIA, 6 (30%) for RF- polyarthritis, 3 (15%) for persistent oligoarthritis, and 2 (10%) for extended oligoarthritis. All children with undifferentiated JIA were ACPA (+); 7 had presentations consistent with oligoarthritis, but had 2 positive RF tests; 1 had a father with psoriasis; 1 was an HLA-B27 (+) boy with onset after age 6. Comparison of children who met criteria for RF+ poly JIA to those who did not revealed significant differences in subtype distribution, number meeting ACR/EULAR criteria for RA, and use of steroids. All other features were not significantly different. The ACR/EULAR criteria for RA captured more children with RF and/or ACPA (+) JIA than the ILAR RF+ poly classification (92% vs. 59%).
Conclusion: A significant number of children (41%) with RF and/or ACPA (+) JIA did not meet criteria for RF+ poly JIA, though many of their demographic features and disease measures were similar to children who did. The ACR/EULAR criteria allow a positive RF or ACPA to qualify as positive serology, and these criteria capture more children with RF and/or ACPA (+) JIA. We propose the inclusion of ACPA in future revisions of the JIA classification criteria to improve the specificity of diagnosing childhood onset RA, and we suggest replacing RF+ polyarthritis with RF/ACPA+ JIA.
Table 1: Characteristics of ACPA and RF positive children with JIA* |
|||
|
RF positive polyarticular JIA |
Non-RF positive polyarticular JIA |
P value** |
Total number |
29 (59) |
20 (41) |
|
Age at symptom onset (mean±SD) |
10.3 ± 3.4 |
9.3 ± 3.9 |
0.34 |
Demographic features Female gender Hispanic ethnicity African ancestry |
22 (76) 7 (14) 9 (18) |
15 (75) 1 (5) 8 (40) |
0.95 0.08 0.52 |
Birth weight (kg; mean±SD) |
3.4 ± 0.5 |
3.3 ± 0.5 |
0.60 |
ACPA value (mean±SD) |
174.5 ± 100.0 |
163.2 ± 100.2 |
0.70 |
ILAR subtype RF + poly RF – poly Oligo extended Oligo persistent Undifferentiated |
29 (100) 0 (0) 0 (0) 0 (0) 0 (0) |
0 (0) 6 (30) 2 (10) 3 (15) 9 (45) |
<0.0001 0.002 0.09 0.03 <0.0001 |
Meets 2010 ACR/EULAR criteria for RA |
29 (100) |
16 (80) |
0.01 |
Imaging evidence of damage |
18 (62) |
7 (35) |
0.07 |
Number of affected joints in first 6 months (mean & range) |
13 (5-30) |
11 (1-48) |
0.48 |
Treatment Use of systemic steroids Use of DMARD Use of biologic |
20 (69) 28 (97) 19 (66) |
7 (35) 17 (85) 8 (40) |
0.02 0.15 0.08 |
*All values are N(%) of those tested/reporting data for particular variables, except as indicated. ACPA: anti-citrullinated protein antibody. **P<0.05 was considered statistically significant |
Disclosure:
E. G. Ferrell,
None;
L. Ponder,
None;
L. Minor,
None;
S. T. Angeles-Han,
None;
C. W. Kennedy,
None;
K. A. Rouster-Stevens,
None;
M. Pichavant,
None;
L. B. Vogler,
None;
S. Prahalad,
None.
« Back to 2012 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/phenotypic-characterization-of-childhood-onset-rheumatoid-arthritis/